Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

Maio, Michele; Grob, Jean-Jacques; Aamdal, Steinar; Bondarenko, Igor; Robert, Caroline; Thomas, Luc; Garbe, Claus; Chiarion-Sileni, Vanna; Testori, Alessandro; Chen, Tai-Tsang; Tschaika, Marina; Wolchok, Jedd D.

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2015-10-30T10:33:11Z
dc.date.available	2015-10-30T10:33:11Z
dc.date.issued	2015
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/10900/66001
dc.language.iso	en	en
dc.publisher	Amer Soc Clinical Oncology	de_DE
dc.relation.uri	http://dx.doi.org/10.1200/JCO.2014.56.6018
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_01054
utue.publikation.seiten	1191-1196	de_DE
utue.personen.roh	Maio, Michele
utue.personen.roh	Grob, Jean-Jacques
utue.personen.roh	Aamdal, Steinar
utue.personen.roh	Bondarenko, Igor
utue.personen.roh	Robert, Caroline
utue.personen.roh	Thomas, Luc
utue.personen.roh	Garbe, Claus
utue.personen.roh	Chiarion-Sileni, Vanna
utue.personen.roh	Testori, Alessandro
utue.personen.roh	Chen, Tai-Tsang
utue.personen.roh	Tschaika, Marina
utue.personen.roh	Wolchok, Jedd D.
dcterms.isPartOf.ZSTitelID	Journal of Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	10	de_DE
dcterms.isPartOf.ZS-Volume	33	de_DE
utue.fakultaet	04 Medizinische Fakultät